Treatment Guidelines for PCOS
The cornerstone of PCOS treatment is lifestyle modification with weight loss of as little as 5% of body weight, followed by targeted medical therapy based on whether the patient is attempting conception, with clomiphene citrate as first-line for fertility and combined oral contraceptive pills for those not seeking pregnancy. 1, 2
Initial Assessment and Screening
All women with PCOS require comprehensive metabolic and cardiovascular screening:
- Screen for type 2 diabetes with fasting glucose followed by 2-hour glucose tolerance test (75-gram glucose load) due to demonstrated increased risk 1
- Screen for dyslipidemia with fasting lipid panel including total cholesterol, LDL, HDL, and triglycerides 1
- Calculate BMI and waist-hip ratio 1
- Screen for psychological features including depression and anxiety, which are highly prevalent 3
Lifestyle Management: Foundation for All Patients
Weight loss of just 5% improves metabolic, reproductive, and psychological outcomes 1, 2. This is based on good evidence showing improvements in ovulation rates, pregnancy rates, testosterone levels, insulin sensitivity, and hirsutism.
Key lifestyle components:
- Regular exercise program (beneficial even without weight loss) 1
- Dietary modification (avoid high-protein diets due to concerns about renal function and lipid effects) 1
- Behavioral modification programs 2
Common pitfall: Weight stigma can harm patient engagement. Address weight-related health risks while minimizing stigma 3, 4.
For Women Attempting Conception
Step 1: Lifestyle First
Begin with weight control and regular exercise for 3-6 months 1
Step 2: Clomiphene Citrate
First-line pharmacotherapy is clomiphene citrate - achieves 80% ovulation rate with 50% conception rate among ovulators 1. This recommendation is based on good and consistent scientific evidence.
Step 3: If Clomiphene Fails
Use low-dose gonadotropin therapy rather than high-dose protocols to achieve monofollicular development and reduce ovarian hyperstimulation risk 1
Metformin Considerations
While metformin improves ovulation frequency, its effects on early pregnancy outcomes remain unclear. Metformin appears safe but documentation is limited for reducing miscarriage rates 1. Insulin-sensitizing agents improve ovulation but are not FDA-approved for PCOS treatment 1.
Surgery
Laparoscopic ovarian drilling (laser or diathermy) has undetermined benefit and role 1
For Women NOT Attempting Conception
Menstrual Regulation and Endometrial Protection
Combined oral contraceptive pills are the primary long-term management 1. Benefits include:
- Suppression of ovarian androgen secretion
- Increased sex hormone binding globulin
- Reduced endometrial cancer risk
- Improved hirsutism and acne
Important caveat: OCPs increase triglycerides and HDL cholesterol in PCOS, though no evidence shows increased cardiovascular events compared to general population 1
Alternative: Medroxyprogesterone acetate (depot or intermittent oral) suppresses androgens and gonadotropins, though optimal progestin type, duration, and frequency for endometrial protection remain unknown 1
Metabolic Management
Interventions improving insulin sensitivity (weight loss, metformin, or thiazolidinediones) may positively impact diabetes and cardiovascular risk factors 1. However, this is based on limited or inconsistent evidence.
Key differences between insulin-sensitizing agents:
- Metformin: Tends to decrease weight, improves or maintains glucose tolerance over time 1
- Thiazolidinediones: Tend to increase weight (troglitazone removed from market due to hepatotoxicity) 1
- Neither class is FDA-approved for PCOS treatment 1
Anti-Obesity Agents (Emerging Evidence)
Recent 2024 evidence suggests GLP-1 receptor agonists (liraglutide, semaglutide) and orlistat show promise for anthropometric outcomes 5. However, published data are very limited with small sample sizes and short study durations (often 12 weeks). The role of these agents in PCOS requires high-priority future research 5.
Practical consideration: When using GLP-1 RAs, combine with resistance training to preserve lean body mass 5
Hirsutism Management
No established primary treatment exists; approach is often palliative rather than curative 1.
Medical Options:
- Combined therapy most effective: Antiandrogen (spironolactone, flutamide, or finasteride) plus oral contraceptive pill 1
- Only FDA-approved agent: Topical eflornithine hydrochloride cream 1
- Insulin-sensitizing agents may help 1
Mechanical Options:
- Plucking, shaving, waxing
- Electrolysis (may be impractical for large areas)
- Laser vaporization (requires multiple treatments)
- Concomitant medical management usually necessary 1
Adolescent-Specific Considerations
Diagnosis in adolescents requires BOTH irregular menstrual cycles (defined by time postmenarche) AND clinical/biochemical hyperandrogenism 4. Do NOT use polycystic ovarian morphology on ultrasound or AMH levels for adolescent diagnosis 4.
Adolescents with only one feature are considered "at risk" and require symptom management with ongoing follow-up 4.
For adolescents with PCOS:
- Combined oral contraceptive pills: Focus on low-dose preparations for menstrual irregularity and hyperandrogenism 4
- Metformin: Consider for metabolic features and cycle regulation 4
- Emphasize lifelong health planning including depression screening 4
Key Evidence Gaps
The evidence quality across PCOS management remains generally low to moderate 3, 6, 7. Critical research needs include:
- Optimal lifestyle intervention components
- Long-term effects of anti-obesity agents (especially newer GLP-1 RAs like semaglutide)
- Optimal screening frequency for metabolic and cardiovascular disease
- Mental health screening tools specific to PCOS
- Adolescent-specific interventions
Bottom line: Despite low-quality evidence, the 2023 International Evidence-Based Guideline 3 provides the most rigorous, multidisciplinary, consumer-engaged recommendations currently available, with 77 evidence-based and 54 consensus recommendations addressing diagnosis, screening, and management across the lifespan.